India Glycols

Why is India Glycols Ltd falling/rising?

As of 10-Jun, India Glycols Ltd's stock price is at 960.50, down 1.77%, and has underperformed the sector. Despite recent declines, the company shows strong financial health with positive returns over the last five quarters, suggesting potential undervaluation.

As of 10-Jun, India Glycols Ltd's stock price is currently at 960.50, reflecting a decline of 17.3 points or 1.77%. The stock has underperformed the sector today by 0.38%, with an intraday low of Rs 949.7, which represents a decrease of 2.87%. Over the past week, the stock has decreased by 2.27%, and in the last month, it has seen a significant drop of 16.67%, while the benchmark Sensex has only fallen by 4.33% during the same period.<BR><BR>Despite these recent declines, the company has shown positive financial performance over the last five quarters, with a return on capital employed (ROCE) of 11.79%, which is the highest recorded. The company also boasts a strong operating profit to interest ratio and a low debt-equity ratio, indicating solid financial health. However, the stock's current price is lower than its 5-day, 20-day, and 50-day moving averages, which may suggest a bearish trend in the short term.<BR><BR>Investor participation has increased, with a delivery volume rise of 3.62% compared to the 5-day average, indicating some interest in the stock despite its recent price decline. The stock has generated a modest return of 2.66% over the past year, while profits have increased by 27.1%, suggesting that the stock may be undervalued compared to its peers.<BR><BR>In summary, the stock of India Glycols Ltd is currently falling due to recent price declines and underperformance against the sector, despite its strong financial fundamentals and consistent returns over the longer term.

Which are the latest news on India Glycols?

Should I buy, sell or hold India Glycols Ltd?

Are India Glycols Ltd latest results good or bad?

India Glycols Ltd's latest Q4 FY26 results show strong profitability with a net profit increase of 28.58% quarter-on-quarter, but a concerning 11.43% decline in net sales compared to the previous quarter. Overall, the results are good in terms of profit but mixed due to the revenue drop.

India Glycols Ltd's latest results for Q4 FY26 present a mixed picture. On one hand, the company achieved a consolidated net profit of ₹86.88 crores, marking a significant 28.58% increase quarter-on-quarter and a remarkable 35.71% growth year-on-year. This reflects strong profitability momentum and operational efficiency.<BR><BR>However, net sales decreased by 11.43% compared to the previous quarter, totaling ₹976.35 crores, although there was a year-on-year increase of 13.11%. This sequential decline in revenue raises some concerns about demand sustainability, especially given the typical seasonal patterns in the chemicals industry.<BR><BR>The operating margin also showed positive signs, reaching 17.05%, which is the highest in several quarters, indicating effective cost management and a focus on higher-margin products. The profit after tax (PAT) margin improved to 8.90%, further underscoring the company's ability to enhance profitability despite revenue pressures.<BR><BR>In summary, while the profit figures are strong and indicate effective operational management, the decline in sales could be a point of concern. Overall, the results can be seen as good in terms of profitability but mixed due to the revenue drop.

When is the next results date for India Glycols Ltd?

The next results date for India Glycols Ltd is 14 May 2026.

The next results date for India Glycols Ltd is scheduled for 14 May 2026.

Has India Glycols Ltd declared dividend?

Yes, India Glycols Ltd has declared a dividend of 150%, amounting to ₹5 per share, with an ex-date of March 23, 2026. The company has demonstrated strong total returns across various periods, with a notable 306.65% total return over the last 5 years.

India Glycols Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 150%<BR>- Amount per share: 5<BR>- Ex-date: 23 Mar 26<BR><BR>Dividend Yield: 0.54%.<BR><BR>Total Returns by Period:<BR>In the last 3 months, the price return was -15.73%, the dividend return was 0.72%, resulting in a total return of -15.01%.<BR><BR>Over the past 6 months, the price return was 3.69%, the dividend return was 1.43%, leading to a total return of 5.12%.<BR><BR>In the 1-year period, the price return was 57.02%, with a dividend return of 2.29%, culminating in a total return of 59.31%.<BR><BR>For the 2-year period, the price return was 123.49%, the dividend return was 5.42%, resulting in a total return of 128.91%.<BR><BR>In the last 3 years, the price return was 200.09%, with a dividend return of 9.19%, leading to a total return of 209.28%.<BR><BR>Over the past 4 years, the price return was 99.42%, the dividend return was 6.71%, resulting in a total return of 106.13%.<BR><BR>In the 5-year period, the price return was 287.34%, with a dividend return of 19.31%, culminating in a total return of 306.65%.<BR><BR>Overall, India Glycols Ltd has declared a significant dividend and has shown strong total returns over various periods, indicating a positive performance trend for the company.

How has been the historical performance of India Glycols?

India Glycols has shown significant growth in net sales and profits, with net sales increasing from 2,316.99 Cr in Mar'21 to 3,768.26 Cr in Mar'25, and profit after tax rising from 129.67 Cr to 184.52 Cr in the same period, despite rising raw material costs. The company's operating profit margin improved to 13.56% in Mar'25, reflecting its strong financial performance.

Answer:<BR>The historical performance of India Glycols shows a significant upward trend in net sales and profit over the years, with the latest figures indicating a robust growth trajectory.<BR><BR>Breakdown:<BR>India Glycols has demonstrated a consistent increase in net sales, rising from 2,316.99 Cr in Mar'21 to 3,768.26 Cr in Mar'25. This growth is accompanied by a rise in total operating income, which reached 3,768.26 Cr in Mar'25, up from 2,650.86 Cr in Mar'23. The company's operating profit (PBDIT) also improved, reaching 525.49 Cr in Mar'25, compared to 319.42 Cr in Mar'23. Profit before tax increased to 245.92 Cr in Mar'25 from 153.63 Cr in Mar'23, while profit after tax rose to 184.52 Cr from 129.67 Cr in the same period. Despite fluctuations in expenses, including a notable increase in raw material costs, the operating profit margin improved to 13.56% in Mar'25 from 11.15% in Mar'23. The total assets of the company grew to 6,176.10 Cr in Mar'25, up from 4,858.33 Cr in Mar'23, while total liabilities also increased to 6,176.10 Cr from 4,858.33 Cr. Cash flow from operating activities was strong at 362.00 Cr in Mar'25, although the company faced a net cash outflow of 20.00 Cr. Overall, India Glycols has shown resilience and growth in its financial performance over the years.

Is India Glycols technically bullish or bearish?

As of 9 October 2025, the trend has shifted to bullish with moderate strength, supported by bullish daily moving averages and positive Bollinger Bands, although caution is advised due to mildly bearish weekly MACD and KST indicators.

As of 9 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators supporting this include the daily moving averages being bullish and both the weekly and monthly Bollinger Bands indicating bullish momentum. However, the weekly MACD and KST are mildly bearish, suggesting some caution. The overall performance metrics show strong returns compared to the Sensex, particularly over longer time frames, reinforcing the bullish outlook.

Is India Glycols overvalued or undervalued?

As of August 8, 2025, India Glycols is considered overvalued with a PE ratio of 22.10, despite outperforming the Sensex with a 34.57% year-to-date return, as it has moved from a fair to an expensive valuation grade compared to its peers.

As of 8 August 2025, India Glycols has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its key financial ratios. The PE ratio stands at 22.10, while the Price to Book Value is 2.39, and the EV to EBITDA is 13.46. These ratios indicate a premium valuation compared to its peers.<BR><BR>In comparison to its industry peers, India Glycols' PE ratio is significantly lower than Solar Industries at 103.57 and Gujarat Fluoroch at 61.32, both categorized as very expensive. However, it is higher than Godrej Industries, which is rated attractive with a PE of 37.72. The company's recent stock performance has outpaced the Sensex, with a year-to-date return of 34.57% compared to the Sensex's 2.20%, but this does not alter the overall assessment of its current valuation.

Who are in the management team of India Glycols?

As of March 2023, the management team of India Glycols includes U S Bhartia (Chairman/Executive Director), Pragya Bhartia Barwale, Sudhir Agarwal (both Executive Directors), and several Independent Non-Executive Directors, ensuring a diverse governance structure.

As of March 2023, the management team of India Glycols includes the following individuals:<BR><BR>1. U S Bhartia - Chairman / Executive Director<BR>2. Jayshree Bhartia - Non Executive Director<BR>3. Pragya Bhartia Barwale - Executive Director<BR>4. Sudhir Agarwal - Executive Director<BR>5. Pradip Kumar Khaitan - Independent Non Executive Director<BR>6. Jitender Balakrishnan - Independent Non Executive Director<BR>7. Ravi Jhunjhunwala - Independent Non Executive Director<BR>8. Jagmohan N Kejriwal - Independent Non Executive Director<BR>9. Sajeve Deora - Independent Non Executive Director<BR>10. Shukla Wassan - Independent Non Executive Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and strategic direction of the company.

Who are the top shareholders of the India Glycols?

The top shareholder of India Glycols is Kashipur Holdings Limited, owning 50.35%. Other notable shareholders include 50 Foreign Institutional Investors with 2.25%, mutual funds with 0.12%, and individual investors holding 28.68%, with Puneet Bhatia as the largest public shareholder at 1.92%.

The top shareholders of India Glycols include Kashipur Holdings Limited, which holds the largest share at 50.35%. The company is primarily owned by its promoters, with no pledged promoter holdings reported. Additionally, there are 50 Foreign Institutional Investors (FIIs) collectively holding 2.25% of the shares, and mutual funds are represented by 8 schemes with a total holding of 0.12%. The highest public shareholder is Puneet Bhatia, who owns 1.92%. Individual investors collectively hold 28.68% of the company's shares.

how big is India Glycols?

As of Jun 06, India Glycols Ltd has a market capitalization of 5,746.14 Cr, with net sales of 3,768.26 Cr and net profit of 230.92 Cr over the latest four quarters. Shareholder's funds are 2,051.02 Cr, and total assets are valued at 5,616.80 Cr as of Mar'24.

Market Cap: As of Jun 06, India Glycols Ltd has a market capitalization of 5,746.14 Cr, classifying it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 3,768.26 Cr, and the sum of Net Profit is 230.92 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the reporting period of Mar'24. The Shareholder's Funds amount to 2,051.02 Cr, and the Total Assets are valued at 5,616.80 Cr.

What does India Glycols do?

India Glycols Ltd is a mid-cap company in the commodity chemicals industry, reporting net sales of ₹863 Cr and a net profit of ₹64 Cr for March 2025. Key metrics include a P/E ratio of 25.00, a dividend yield of 0.42%, and a market cap of ₹5,764 Cr.

Overview:<BR>India Glycols Ltd operates in the commodity chemicals industry and is classified as a mid-cap company.<BR><BR>History:<BR>The company was incorporated as UP Glycols Limited and later changed its name to India Glycols Limited in September 1986. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 863 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 64 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 5,764 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 25.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.42% <BR>Debt-Equity: 0.80 <BR>Return on Equity: 10.24% <BR>Price to Book: 2.59 <BR><BR>Contact Details:<BR>Address: A-1 Industrial Area, Bazpur Road Kashipur Udham Singh Nagar UTT : 244713 <BR>Tel: 91-05947-269000/269500/275320 <BR>Email: compliance.officer@indiaglycols.com <BR>Website: http://www.indiaglycols.com

Who are the peers of the India Glycols?

India Glycols' peers include Tata Chemicals, Chemplast Sanmar, GHCL, and others. It has the highest 1-year return at 150.38%, while Gujarat Alkalies has the lowest at -25.63%.

Peers: The peers of India Glycols are Tata Chemicals, Chemplast Sanmar, GHCL, Fischer Medical, Gujarat Alkalies, Grauer & Weil, Tanfac Inds., Thirumalai Chem., Blue Pearl Agri, and J.G.Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Grauer & Weil, Tanfac Inds., Thirumalai Chem., and J.G.Chemicals. Below Average management risk is noted at Fischer Medical and Gujarat Alkalies. For Growth, Excellent growth is seen at Tanfac Inds., while Below Average growth is present at Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, Fischer Medical, Gujarat Alkalies, Grauer & Weil, Thirumalai Chem., and J.G.Chemicals. The Capital Structure is Excellent for GHCL, Gujarat Alkalies, and Tanfac Inds., Average for Tata Chemicals, India Glycols, Thirumalai Chem., and Grauer & Weil, and Below Average for Chemplast Sanmar and Fischer Medical.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.38%, while Gujarat Alkalies has the lowest at -25.63%. Compared to its peers, India Glycols' return is significantly higher. Additionally, the peers with negative six-month returns include Tata Chemicals, Gujarat Alkalies, Grauer & Weil, and Thirumalai Chem.